Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Dublin

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
JAMA Internal Medicine|January 27, 2015
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort studyShelly L Gray, Melissa L Anderson, Sascha Dublin, et al.
Journal of General Internal Medicine|July 29, 2022
External Validation of the eRADAR Risk Score for Detecting Undiagnosed Dementia in Two Real-World Healthcare SystemsR Yates Coley, Julia J Smith, Leah Karliner, et al.
Clinical and Translational Science|November 23, 2022
Antidepressant drug-drug-drug interactions associated with unintentional traumatic injury: Screening for signals in real-world dataCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
Pharmacoepidemiology and Drug Safety|February 13, 2013
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrualTaliser R Avery, Martin Kulldorff, Yury Vilk, et al.
JAMA Internal Medicine|November 27, 2023
Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical TrialKristine Yaffe, Eric Vittinghoff, Sascha Dublin, et al.
The International Journal on Drug Policy|July 1, 2017
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiativesMichael Von Korff, Rod L Walker, Kathleen Saunders, et al.
Pain Medicine (Malden, Mass.)|December 9, 2017
Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse OutcomesManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Archives of Internal Medicine|February 14, 2007
Newly detected atrial fibrillation and compliance with antithrombotic guidelinesNicole L Glazer, Sascha Dublin, Nicholas L Smith, et al.
The Journal of Pain|October 18, 2017
Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual CareManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Journal of the American Geriatrics Society|March 2, 2016
Incident Atrial Fibrillation and Disability-Free Survival in the Cardiovascular Health StudyErin R Wallace, David S Siscovick, Colleen M Sitlani, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
JAMA Internal Medicine|January 27, 2015
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort studyShelly L Gray, Melissa L Anderson, Sascha Dublin, et al.
Journal of General Internal Medicine|July 29, 2022
External Validation of the eRADAR Risk Score for Detecting Undiagnosed Dementia in Two Real-World Healthcare SystemsR Yates Coley, Julia J Smith, Leah Karliner, et al.
Clinical and Translational Science|November 23, 2022
Antidepressant drug-drug-drug interactions associated with unintentional traumatic injury: Screening for signals in real-world dataCheng Chen, Sean Hennessy, Colleen M Brensinger, et al.
Pharmacoepidemiology and Drug Safety|February 13, 2013
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrualTaliser R Avery, Martin Kulldorff, Yury Vilk, et al.
JAMA Internal Medicine|November 27, 2023
Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical TrialKristine Yaffe, Eric Vittinghoff, Sascha Dublin, et al.
The International Journal on Drug Policy|July 1, 2017
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiativesMichael Von Korff, Rod L Walker, Kathleen Saunders, et al.
Pain Medicine (Malden, Mass.)|December 9, 2017
Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse OutcomesManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Archives of Internal Medicine|February 14, 2007
Newly detected atrial fibrillation and compliance with antithrombotic guidelinesNicole L Glazer, Sascha Dublin, Nicholas L Smith, et al.
The Journal of Pain|October 18, 2017
Comparing Pain and Depressive Symptoms of Chronic Opioid Therapy Patients Receiving Dose Reduction and Risk Mitigation Initiatives With Usual CareManu Thakral, Rod L Walker, Kathleen Saunders, et al.
Journal of the American Geriatrics Society|March 2, 2016
Incident Atrial Fibrillation and Disability-Free Survival in the Cardiovascular Health StudyErin R Wallace, David S Siscovick, Colleen M Sitlani, et al.
Pageof 13